Visby Medical™ announced that it will make its debut appearance at the 40th Annual J.P. Morgan Healthcare Conference.
Category: Press Release
Visby Medical Appoints Terri S. Bresenham and Scott Edward Mendel to Board of Directors
Visby Medical™ today announced Terri S. Bresenham and Scott Edward Mendel have been appointed to the company’s Board of Directors.
Clinical Data of The Visby Medical Sexual Health Click Test Published in Journal of the American Sexually Transmitted Diseases Association
Integration of the Visby Medical sexually transmitted infections (STI) panel into clinical practice could significantly reduce over- and under-treatment of Chlamydia, Gonorrhea, and Trichomonas
Visby Medical Appoints Industry Veteran Thomas Prescott as Chairman of the Board
Thomas Prescott, former president and chief executive officer (CEO) of Align Technology and Cardiac Pathways, will join as the company’s new chairman of the board.
Visby Medical Appoints Industry Veteran John W. Kuo as Chief Legal Officer
Visby Medical™, a leading medical diagnostic company, today announced the appointment of John W. Kuo as the company’s new Chief Legal Officer. An experienced veteran in corporate law, Kuo brings more than 30 years of experience across multiple industries, including nearly 20 years in the healthcare industry.
FDA Grants Emergency Use Authorization for Visby Medical’s COVID-19 RT-PCR Test for Pooled Samples
The Visby Medical™ instrument-free Reverse Transcription (RT)-Polymerase Chain Reaction (PCR) COVID-19 test was granted Emergency Use Authorization (EUA) by the FDA
Visby Medical™ Receives FDA Clearance and CLIA Waiver at the Point of Care for PCR Sexual Health Test
The Visby Medical Sexual Health Click Test is the first instrument-free PCR test for the detection of Chlamydia, Gonorrhea, and Trichomonas, with results available within 30 minutes, during the patient visit.
Visby Medical Makes Strategic Hires to Continue Business Development
Visby Medical appoints Mark Ibison as Chief Financial Officer, Christopher J. Jowett as Chief Commercial Officer, and Alicia Zuiker as Chief People Officer
Visby Medical’s COVID-19 PCR Point of Care Test Authorized for Use in CLIA Waived Settings
Expanding critical access to the only single-use, rapid PCR test, at the point of care.
Visby Medical speeds development of a rapid Flu-COVID PCR test designed for at-home use with BARDA funding
Visby Medical pairs speed with the accuracy of gold-standard PCR testing in a single-use device, so doctors don’t have to fight blind.